FDA Approves First Interchangeable Biosimilar Insulin

FDA Approves First Interchangeable Biosimilar Insulin

The US Meals and Drug Administration (FDA) has well-liked the principle interchangeable insulin, Semglee (Mylan Prescribed capsules), that also can merely be substituted for glargine (Lantus, Sanofi) on the pharmacy with out the necessity for a separate prescription. The approval…